NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG

Journal of Molecular Biology

Volumn 416, Issue 1, 2012, Pages 108-120

  Huang, Rui ^a   Vivekanandan, Subramanian ^a   Brender, Jeffrey R ^a   Abe, Yuki ^b   Naito, Akira ^b   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b YOKOHAMA NATIONAL UNIVERSITY   (Japan)

Author keywords

amyloid peptide; calcitonin; conformation; EGCG; oligomerization

Indexed keywords

CALCITONIN; EPIGALLOCATECHIN GALLATE; MONOMER; OLIGOMER; PHENYLALANINE; TYROSINE;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBER; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84856492181     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.12.023     Document Type: Article

References (69)

1. Copp D.H., Davidson A.G., Henze K.G., Cheney B.A., and Cameron E.C. Evidence for calcitonin-a new hormone from parathyroid that lowers blood calcium Endocrinology 70 1962 638 649
2. Austin L.A., and Heath H. Calcitonin: physiology and pathophysiology N. Engl. J. Med. 304 1981 269 278
3. Chambers T.J. Osteoblasts release osteoclasts from calcitonin-induced quiescence J. Cell Sci. 57 1982 247 260 (Pubitemid 13220120)
4. Chambers T.J., and Magnus C.J. Calcitonin alters behavior of isolated osteoclasts J. Pathol. 136 1982 27 39 (Pubitemid 12213616)
5. Zaidi M., Inzerillo A.M., Moonga B.S., Bevis P.J.R., and Huang C.L.H. Forty years of calcitonin-where are we now? A tribute to the work of Iain Macintyre, FRS Bone 30 2002 655 663 (Pubitemid 34467985)
6. Breimer L.H., Macintyre I., and Zaidi M. Peptides from the calcitonin genes: molecular genetics, structure and function Biochem. J. 255 1988 377 390
7. Henriksen K., Bay-Jensen A.C., Christiansen C., and Karsdal M.A. Oral salmon calcitonin-pharmacology in osteoporosis Expert Opin. Biol. Ther. 10 2010 1617 1629
8. Zurdo J., Fowler S.B., Poon S., Muff R., Chiti F., and Dobson C.M. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin Proc. Natl Acad. Sci. USA 102 2005 10105 10110 (Pubitemid 41023333)
9. Malchiodi-Albedi F., Vanacore N., and Diociaiuti M. Calcitonin therapy and oligomer neurotoxicity: an underestimated risk? Neurotoxicology 29 2008 1150 1151
10. Cromwell M.E.M., Hilario E., and Jacobson F. Protein aggregation and bioprocessing AAPS J. 8 2006 E572 E579
11. Sieber P., Riniker B., Brugger M., Kamber B., and Rittel W. Human calcitonin. VI. Synthesis of calcitonin Helv. Chim. Acta 53 1970 2135 2150
12. 13C NMR Protein Sci. 9 2000 867 877 (Pubitemid 30353328)
13. 13C NMR J. Biol. Chem. 278 2003 2859 2865 (Pubitemid 36801190)
14. 13C solid-state NMR spectroscopy Magn. Reson. Chem. 42 2004 247 257 (Pubitemid 38178094)
15. Gazit E., Reches M., and Porat Y. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin J. Biol. Chem. 277 2002 35475 35480
16. Jelinek R., Shtainfeld A., and Sheynis T. Specific mutations alter fibrillation kinetics, fiber morphologies, and membrane interactions of pentapeptides derived from human calcitonin Biochemistry 49 2010 5299 5307
17. Andreotti G., and Motta A. Modulating calcitonin fibrillogenesis. An antiparallel α-helical dimer inhibits fibrillation of salmon calcitonin J. Biol. Chem. 279 2004 6364 6370 (Pubitemid 38248769)
18. Arvinte T., Cudd A., and Drake A.F. The structure and mechanism of formation of human calcitonin fibrils J. Biol. Chem. 268 1993 6415 6422 (Pubitemid 23099338)
19. Kanaori K., and Nosaka A.Y. Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy Biochemistry 34 1995 12138 12143
20. Conway K.A., Rochet J.C., Bieganski R.M., and Lansbury P.T. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α- synuclein adduct Science 294 2001 1346 1349 (Pubitemid 33063102)
21. Williams A.D., Sega M., Chen M.L., Kheterpal I., Geva M., and Berthelier V. Structural properties of Aβ protofibrils stabilized by a small molecule Proc. Natl Acad. Sci. USA 102 2005 7115 7120 (Pubitemid 40696343)
22. Cohen T., Frydman-Marom A., Rechter M., and Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives Biochemistry 45 2006 4727 4735
23. Meng F.L., Abedini A., Plesner A., Middleton C.T., Potter K.J., and Zanni M.T. The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation J. Mol. Biol. 400 2010 555 566
24. Bieschke J., Russ J., Friedrich R.P., Ehrnhoefer D.E., Wobst H., Neugebauer K., and Wanker E.E. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity Proc. Natl Acad. Sci. USA 107 2010 7710 7715
25. Masuda M., Suzuki N., Taniguchi S., Oikawa T., Nonaka T., and Iwatsubo T. Small molecule inhibitors of α-synuclein filament assembly Biochemistry 45 2006 6085 6094 (Pubitemid 43727101)
26. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., and Lurz R. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 2008 558 566 (Pubitemid 351799141)
27. Mandel S.A., Amit T., Weinreb O., Reznichenko L., and Youdim M.B.H. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases CNS Neurosci. Ther. 14 2008 352 365
28. Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., and Roark M. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models Hum. Mol. Genet. 15 2006 2743 2751 (Pubitemid 44400401)
29. Meng F.L., Abedini A., Plesner A., Verchere C.B., and Raleigh D.P. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity Biochemistry 49 2010 8127 8133
30. Chandrashekaran I.R., Adda C.G., MacRaild C.A., Anders R.F., and Norton R.S. Inhibition by flavonoids of amyloid-like fibril formation by plasmodium falciparum merozoite surface protein 2 Biochemistry 49 2010 5899 5908
31. Meng X.Y., Munishkina L.A., Fink A.L., and Uversky V.N. Molecular mechanisms underlying the flavonoid-induced inhibition of α-synuclein fibrillation Biochemistry 48 2009 8206 8224
32. 1H NMR J. Phys. Chem. Lett. 2 2011 735 740
33. Rezaei-Ghaleh N., Andreetto E., Yan L.M., Kapurniotu A., and Zweckstetter M. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide PLoS One 6 2011 e20289
34. Narayanan S., and Reif B. Characterization of chemical exchange between soluble and aggregated states of β-amyloid by solution-state NMR upon variation of salt conditions Biochemistry 44 2005 1444 1452 (Pubitemid 40204388)
35. Soong R., Brender J.R., Macdonald P.M., and Ramamoorthy A. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy J. Am. Chem. Soc. 131 2009 7079 7085
36. 10-helix secondary structure in rabbit liver metallothionein-2 J. Mol. Biol. 187 1986 131 135
37. Hauber I., Hohenberg H., Holstermann B., Hunstein W., and Hauber J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection Proc. Natl Acad. Sci. USA 106 2009 9033 9038
38. Hudson S.A., Ecroyd H., Dehle F.C., Musgrave I.F., and Carver J.A. (-)-Epigallocatechin-3-gallate (EGCG) maintains κ-casein in its pre-fibrillar state without redirecting its aggregation pathway J. Mol. Biol. 392 2009 689 700
39. Ferreira N., Cardoso I., Domingues M.R., Vitorino R., Bastos M., and Bai G.Y. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity FEBS Lett. 583 2009 3569 3576
40. Roberts B.E., Duennwald M.L., Wang H., Chung C., Lopreiato N.P., and Sweeny E.A. A synergistic small-molecule combination directly eradicates diverse prion strain structures Nat. Chem. Biol. 5 2009 936 946
41. Wilkins D.K., Grimshaw S.B., Receveur V., Dobson C.M., Jones J.A., and Smith L.J. Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques Biochemistry 38 1999 16424 16431
42. Vivekanandan S., Brender J.R., Lee S.Y., and Ramamoorthy A. A partially folded structure of amyloid-beta(1-40) in an aqueous environment Biochem. Biophys. Res. Commun. 411 2011 312 316
43. Brender J.R., Nanga R.P.R., Popovych N., Soong R., Macdonald P.M., and Ramamoorthy A. The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency Biochim. Biophys. Acta 1808 2011 1161 1169
44. Uversky V.N., and Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 1698 2004 131 153 (Pubitemid 38591469)
45. Abedini A., and Raleigh D.P. A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides Protein Eng. Des. Sel. 22 2009 453 459
46. 1H NMR study of human calcitonin in solution Biochemistry 30 1991 2364 2371
47. Benedek G.B., Yong W., Lomakin A., Kirkitadze M.D., Teplow D.B., and Chen S.H. Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering Proc. Natl Acad. Sci. USA 99 2002 150 154 (Pubitemid 34060332)
48. Rhoades E., and Gafni A. Micelle formation by a fragment of human islet amyloid polypeptide Biophys. J. 84 2003 3480 3487 (Pubitemid 36531790)
49. Padrick S.B., and Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 2002 4694 4703 (Pubitemid 34275671)
50. Estelrich J., and Sabate R. Evidence of the existence of micelles in the fibrillogenesis of β-amyloid peptide J. Phys. Chem. B 109 2005 11027 11032 (Pubitemid 40844540)
51. Jean L., Lee C.F., Lee C., Shaw M., and Vaux D.J. Competing discrete interfacial effects are critical for amyloidogenesis FASEB J. 24 2010 309 317
52. Fawzi N.L., Ying J., Torchia D.A., and Clore G.M. Kinetics of amyloid β monomer-to-oligomer exchange by NMR relaxation J. Am. Chem. Soc. 132 2010 9948 9951
53. Campbell A.P., and Sykes B.D. The two-dimensional transferred nuclear Overhauser effect: theory and practice Annu. Rev. Biophys. Biomol. Struct. 22 1993 99 122 (Pubitemid 23180318)
54. Tsai H.H., Zanuy D., Haspel N., Gunasekaran K., Ma B.Y., Tsai C.J., and Nussinov R. The stability and dynamics of the human calcitonin amyloid peptide DFNKF Biophys. J. 87 2004 146 158
55. Miyata M., Sato T., Kugimiya M., Sho M., Nakamura T., and Ikemizu S. The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site Biochemistry 49 2010 6104 6114
56. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., and Apostol M.I. Atomic structures of amyloid cross-β spines reveal varied steric zippers Nature 447 2007 453 457 (Pubitemid 46816731)
57. Luca S., Yau W.M., Leapman R., and Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 2007 13505 13522 (Pubitemid 350209947)
58. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., and Doeli H. 3D structure of Alzheimer's amyloid-β(1-42) fibrils Proc. Natl Acad. Sci. USA 102 2005 17342 17347
59. Yu L.P., Edalji R., Harlan J.E., Holzman T.F., Lopez A.P., and Labkovsky B. Structural characterization of a soluble amyloid β-peptide oligomer Biochemistry 48 2009 1870 1877
60. Lindquist S.L., Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., and Moslehi J.J. Nucleated conformational conversion and the replication of conformational information by a prion determinant Science 289 2000 1317 1321 (Pubitemid 30656041)
61. 1H NMR spectroscopy Biochemistry 35 1996 12671 12676 (Pubitemid 26337321)
62. Ellman G.L. A colorimetric method for determining low concentrations of mercaptans Arch. Biochem. Biophys. 74 1958 443 450
63. Tanner J.E. Use of stimulated echo in NMR diffusion studies J. Chem. Phys. 52 1970 2523 2526
64. Mills R. Self-diffusion in normal and heavy water in the range 1-45° J. Phys. Chem. 77 1973 685 688
65. Stejskal E.O., and Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient J. Chem. Phys. 42 1965 288 292
66. Guntert P., Mumenthaler C., and Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA J. Mol. Biol. 273 1997 283 298 (Pubitemid 27460230)
67. Guntert P. Automated NMR structure calculation with CYANA Methods Mol. Biol. 278 2004 353 378
68. Garrett D.S., Powers R., Gronenborn A.M., and Clore G.M. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams J. Magn. Reson. 95 1991 214 220
69. Cornilescu G., Delaglio F., and Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology J. Biomol. NMR 13 1999 289 302 (Pubitemid 29143535)